Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma

Jaclyn Beca,Kaiwan Raza,Elena Mow,James Keech,C. Tom Kouroukis

Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma

2020

Jaclyn Beca
Kaiwan Raza
Elena Mow
James Keech
C. Tom Kouroukis

AbstractThe International Extranodal Lymphoma Study Group-32 (IELSG32) randomized patients with primary central nervous system lymphoma (PCNSL) for induction treatment with methotrexate-cytarabine,...

Keywords:

Methotrexate
Immunology
ThioTEPA
Cost-effectiveness analysis
Diabetes mellitus
Internal medicine
Rituximab
Oncology
Primary central nervous system lymphoma
Medicine
Cytarabine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations